Pre-Test Primary Care Considerations for the Diagnosis and Management of Migraine: Novel Strategies for the Treatment of Episodic Migraine Pre-Test In the United States, Hispanic patients with headaches are _____ less likely to receive a migraine diagnosis compared to White patients with headaches. 20% 30% 40% 50% Unsure Which of the following is expressed in both the peripheral and central nervous systems, including the trigeminovascular pathways, and is elevated during migraine attacks? Calcitonin gene-related peptide (CGRP) Formyl peptide receptor (FPR) Glucagon-like peptide (GLP) Relaxin family peptide receptor (RXFP) Unsure Which of the following is an intranasal formulation for the acute treatment of migraine in adults that received FDA approval based on statistically superior results of pain freedom and freedom from the most bothersome symptom at two hours post-dose? Atogepant Rimegepant Ubrogepant Zavegepant Unsure Which of the following is an oral medication indicated for both the acute treatment of migraine and prevention of episodic migraine in adults? Atogepant Rimegepant Ubrogepant Zavegepant Unsure How confident are you in your ability to implement personalized treatment plans for patients with episodic migraine across diverse patient populations? Very confident Confident Somewhat confident Not very confident Not at all confident
